Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John A. Lewicki currently holds 78,630 shares of Mereo BioPharma Group plc (MREO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John A. Lewicki has been a net seller of MREO stock. They have purchased $0 and sold $2.1M worth of shares.
John A. Lewicki's most recent insider trade was on Sep 13, 2024, when they sold 10,937 shares at $4.22 per share.
John A. Lewicki serves as Executive at Mereo BioPharma Group plc (MREO). They have executed 70 insider transactions totaling $2.1M over their tenure at the company.
John A. Lewicki holds the position of Executive at Mereo BioPharma Group plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
John A. Lewicki has shown a selling trading pattern, with $0 in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John A. Lewicki was on Jun 16, 2015, when they sold $214.4K worth of OMED shares. This transaction involved 8,500 shares at $25.22 per share.
John A. Lewicki currently owns 78,630 shares of Mereo BioPharma Group plc (MREO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John A. Lewicki's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John A. Lewicki has 70 Form 4 filings on record as an insider at Mereo BioPharma Group plc.
Set alerts for John A. Lewicki and 40,000+ other insiders.